KINNATE BIOPHARMA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.65 USD | -0.38% |
|
-.--% | +11.81% |
| Jun. 13 | Kinnate Biopharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 03 | Kinnate Biopharma Inc. Announces Board Resignations | CI |
Performance
| 1 day | -0.38% | ||
| 6 months | +3.11% | ||
| Current year | +11.81% | ||
| 1 year | -13.11% | ||
| 3 years | -88.30% |
Volumes
marketsDaily volume
2 812 224
Estimated daily volume
2 812 224
Record volume 1
62 393 172
Record volume 2
4 022 616
Record volume 3
3 340 489
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
125 147 076
Net sales ()
0
Number of employees
27
Sales / Employee ()
0
Sales / Employee (USD)
0
Free-Float
99.86 %
Free-Float capitalization (USD)
124 977 699
Highs and lows
Current year
2.20
2.69
1 year
1.043.37
3 years
1.0426.05
5 years
1.0448.75
10 years
1.0448.75
Indicators
Moving average 5 days
2.66
Moving average 100 days
2.36
Price spread / (MMA5)
+0.19%
Price spread / (MMA100)
-10.83%
RSI 9 days
0.00
RSI 14 days
0.00
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -0.38% | -.--% | +11.81% | -13.11% | 125M | ||
| +1.18% | +1.29% | +18.09% | -4.59% | 44.48B | ||
| +1.07% | +2.64% | +44.19% | -3.52% | 40.57B | ||
| -0.50% | +2.50% | -8.38% | -3.40% | 38.82B | ||
| +1.19% | +3.65% | +34.66% | +29.00% | 32.22B | ||
| -1.34% | +1.60% | -8.34% | +24.54% | 27.84B | ||
| +1.44% | +3.35% | +16.10% | +34.52% | 26.79B | ||
| +2.05% | +5.85% | +49.73% | +47.55% | 14.31B | ||
| +1.97% | +3.96% | +36.71% | +73.31% | 12.7B | ||
| +1.09% | +0.87% | -6.60% | -13.00% | 11.23B | ||
| +0.43% | +0.64% | -14.25% | -2.92% | 10.4B | ||
| +2.42% | +1.11% | -8.36% | -11.71% | 8.89B | ||
| -3.32% | +15.01% | +48.05% | +56.05% | 7.25B | ||
| +0.61% | +6.35% | +25.70% | +96.29% | 7.22B | ||
| +0.94% | +2.14% | +32.38% | +14.66% | 7.12B | ||
| +1.72% | +4.93% | -5.42% | +14.53% | 6.86B | ||
| Average | +0.58% | +3.53% | +16.63% | +21.14% | ||
| Weighted average by Cap. | +0.51% | +3.05% | +17.51% | +15.83% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | +11.81% | ||
| 2023 | -61.15% | ||
| 2022 | -65.58% | ||
| 2021 | -55.46% | ||
| 2020 | +1.92% |
- Stock Market
- Equities
- KNTE Stock
- Quotes Kinnate Biopharma Inc.
